Dr. Vince Clinical Research

Happy Holidays from Dr. Vince Clinical Research! Our team wishes you joyful holiday festivities and a prosperous year ahead. #happyholidays #merrychristmas #christmas #happynewyears #nye #newyears2025 #drvinceclinicalresearch #dvcr

The seventh installment of “Preskorn’s Perspective” continued exploration on daridorexant, lemborexant and suvorexant. Dr. Preskorn focused on the metabolizing enzyme for each drug, drug-drug interactions and dosing recommendations in patients with organ impairment. Read Dr. Preskorn’s article here: https://lnkd.in/ecYfnsz8 #psychiatry #neuroscience #neurobiology #innovation #pharmacokinetics #drugdevelopment #clinicalresearch #drvinceclinicalresearch #DVCR

We are pleased to announce our upcoming webinar, “Acute Pain Models in Drug Development,” on January 28, 2025. This exclusive webinar will provide in-depth insights into the complexities of acute pain models, their role in drug development and the future of pain therapeutics. What you will learn: • Common Acute Pain Models: Overview of pain models like third molar extraction, abdominoplasty and bunionectomy, highlighting their benefits and limitations. • Bunionectomy Insights: Understand why bunionectomy is a leading pain model with high assay sensitivity for evaluating analgesics. • Standardized Pain Models: Discover how standardization reduces variability through controlled techniques and environments. 👉 Register today! https://lnkd.in/d8nFX8_4 #upcomingwebinar #acutepainmodels #humanpainmodels #bunionectomy #analgesics #drugdevelopment #painmanagement #drvinceclinicalresearch #DVCR

In the sixth installment of “Preskorn’s Perspective,” Dr. Preskorn explored the pharmacokinetics of three FDA-approved dual orexin receptor antagonists - daridorexant, lemborexant and suvorexant - as sleep medications, with principles that broadly apply across all sleep medication classes. Read the full article here: https://lnkd.in/eSX9Jxx3 #psychiatry #neuroscience #neurobiology #innovation #pharmacokinetics #drugdevelopment #clinicalresearch #drvinceclinicalresearch #DVCR

Meet with Sheldon Preskorn, MD, Senior VP of Neuroscience at Dr. Vince Clinical Research at the 63rd Annual Meeting of the American College of Neuropsychopharmacology (ACNP), from December 8-11, 2024. This forum offers the opportunity to connect with world-renowned industry experts and explore information about brain, behavior and psychotropic drugs. #ACNP #ACNP2024 #psychotropicdrugs #neuroscience #clinicalresearch #psychopharmacology #DVCR #drvinceclinicalresearch

If you are attending the American Epilepsy Society 2024 Annual Meeting, don’t miss the chance to connect with Ben Abrams, Director of Business Development at Dr. Vince Clinical Research to learn more about DVCR’s therapeutic expertise in neurology. #AES #AES2024 #neurology #epilepsy #DVCR #drvinceclinicalresearch

If you missed our recent webinar, “Effective Study Design and Execution of Renal and Hepatic Impairment Trials,” it is now available to watch on our website. Learn strategies to optimize organ impairment study outcomes such as effective site selection, expert protocol-design, appropriate patient care and the use of clinical pharmacology tools from industry experts at Dr. Vince Clinical Research and Elixia. Watch the webinar on-demand now: https://lnkd.in/ee27bJpN #webinar #renal #hepatic #studydesign #patientcare #clinicalpharmacology #siteselection #registertoday #DVCR #drvinceclinicalresearch

We're #hiring a new Marketing Manager in Overland Park, Kansas. Apply today or share this post with your network.

Dr. Vince Clinical Research partnered with Cessation Therapeutics to conduct a First-In-Human (FIH) clinical study of an anti-fentanyl antibody designed to reduce opioid toxicity and prevent overdoses. Given the complexities of a FIH clinical study and the Investigational Product (IP), the trial required robust safety protocols, precise drug dosing and effective trial management to ensure reliable results. Explore the white paper to learn how DVCR’s expertise in First-In-Human trials ensured the study was a success through timely and on-budget completion while delivering high-quality data. https://bit.ly/4grIakc #fih #firstinhuman #singleascendingdose #clinicaltrial #drugdevelopment #opioidcrisis #whitepaper #casestudy #drvinceclinicalresearch #DVCR

Why partner with Dr. Vince Clinical Research? Learn why our clients recommend DVCR for their clinical studies. #testimonial #clinicalstudy #clinicalresearch #clinicaltrial #cro #contractresearchorganization #drugdevelopment #drvinceclinicalresearch #DVCR